solid tumors

CRANFORD, New Jersey, May 26, 2026 Citius Oncology, Inc. has announced that new Phase 1 clinical study data evaluating...

COPENHAGEN, Denmark, May 26, 2026 Adcendo ApS has announced a new clinical collaboration and supply agreement with MSD (Merck...

CHICAGO, Illinois, 21 May 2026 A2 Biotherapeutics, Inc. announced new safety and efficacy results from its ongoing EVEREST-2 Phase...

Tel Aviv, Israel and Oslo, Norway – May 22, 2026 BioLineRx Ltd. and Hemispherian AS announced new preclinical and...

NASHIK, India, May 21, 2026 Datar Cancer Genetics (DCG) has achieved a major milestone in precision oncology after receiving...

ESPOO, Finland, May 21, 2026 Orion Pharma announced that it will present the first clinical data from its ongoing...

CARY, N.C. and BRADENTON, Fla., May 20, 2026 Continuity Biosciences has announced the initiation of a Phase I first-in-human...

CAMBRIDGE, UK, May 19, 2026 Mestag Therapeutics announced the first patient has been dosed in the Phase 1 STARLYS...

CHENGDU, China, May 12, 2026 Kelun-Biotech announced that China’s Center for Drug Evaluation (CDE) under the National Medical Products...

OSLO, Norway, May 6, 2026 Zelluna ASA announced the activation of the first clinical site for its ZIMA-101 Phase...